Skip to main content
MPS Limited logo

MPS Limited — Investor Relations & Filings

Ticker · MPSLTD ISIN · INE943D01017 LEI · 335800A5U6IGV9FKPQ98 BSE.NS Publishing, broadcasting, and content production and distribution activities
Open in API
Filings indexed 795 across all filing types
Latest filing 2026-02-02 Investor Presentation
Country IN India
Listing BSE.NS MPSLTD

About MPS Limited

https://www.mpslimited.com/

MPS Limited provides strategic platforms and content solutions for the digital world. The company specializes in content creation, production, and distribution services for academic, educational, and corporate publishers. Its core offerings include editorial services, digital production, and technology-driven platforms designed to streamline the content lifecycle. Key products include DigiCore for automated production and Mag+ for mobile publishing. MPS serves a global clientele, focusing on scientific, technical, and medical (STM) publishing, as well as higher education and corporate learning sectors. The company emphasizes a digital-first approach, leveraging automation and advanced workflows to enhance efficiency and reach across multiple media formats.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Earnings Presentation on Un-Audited Financial Results of the Company for the Third Quarter (Q3) and Nine Months ended on 31 December 2025'. It contains detailed financial performance data for Q3 FY26 and 9M FY26, including revenue, EBITDA, PBT, PAT, margins, segmental revenue breakdown, and operational highlights. The document is a presentation format with forward-looking statements and detailed financial metrics, typical of an earnings presentation. It is not a brief announcement or a certification letter, nor is it a full annual or interim report. The document is clearly an earnings presentation accompanying quarterly financial results, not the initial earnings release (which would be shorter and more summary), nor a full interim report with comprehensive financial statements. Therefore, the most appropriate classification is 'Investor Presentation' (IP).
2026-02-02 English
Outcome of Board Meeting
Regulatory Filings
2026-02-02 English
Press Release
M&A Activity Classification · 95% confidence The document is a press release announcing the acquisition of Unbound Medicine, Inc. by MPS North America LLC, a wholly-owned subsidiary of MPS Limited. It is addressed to stock exchanges and references compliance with SEBI regulations. The content focuses on the strategic rationale, company background, and statements from CEOs about the acquisition. There are no financial statements, detailed financial performance data, or regulatory certifications included. The document is an announcement of a merger/acquisition transaction rather than a full merger filing or proxy statement. Therefore, it fits best under the category for M&A Activity announcements (TAR).
2026-01-30 English
Acquisition
M&A Activity Classification · 95% confidence The document is a detailed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the acquisition of 100% stake in Unbound Medicine, Inc. by a wholly-owned subsidiary of MPS Limited. It includes comprehensive information about the acquisition agreement, strategic rationale, business background of the acquired entity, financial details, regulatory compliance, and expected synergies. The document is not a financial report, earnings release, or management discussion but an official announcement of a significant corporate transaction (acquisition). This fits the definition of M&A Activity (TAR) filings, which cover announcements and documents related to merger proposals or takeover bids. The document length is substantial and contains detailed transaction information, not just a brief announcement or press release, confirming it is a full M&A disclosure rather than a simple report publication or regulatory filing. Therefore, the correct classification is TAR with high confidence.
2026-01-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about the schedule of an earnings conference call for the third quarter and nine months ended 31 December 2025. It includes details about the date, time, participants, and dial-in information for the call. There is no actual financial data or results presented in the document; it is purely an announcement of the upcoming earnings call event. According to the classification rules, such a document is best classified as a Call Transcript (CT) only if it contains the full transcript of the call, which this does not. It is also not an Earnings Release (ER) since it does not contain financial highlights or results. The document is an announcement of the earnings call schedule, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories. The document length is short (3605 characters), and it is an announcement rather than the report or transcript itself.
2026-01-28 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.